Single Vector AAV Approach to Genome Editing in Pompe Disease

被引：0
|
作者：
Arnson, Benjamin [1 ]
Wang, Jason [2 ]
Courtney, David [3 ]
Han, Sang-oh [1 ]
Li, Songtao [1 ]
Cullen, Bryan R. [3 ]
Bursac, Nenad [2 ]
Koeberl, Dwight [1 ]
机构：
[1] Duke Univ, Pediat Med Genet, Durham, NC USA
[2] Duke Univ, Biomed Engn, Durham, NC USA
[3] Duke Univ, Mol Genet & Microbiol, Durham, NC USA
来源：
MOLECULAR THERAPY | 2021年 / 29卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
600
引用
收藏
页码：291 / 291
页数：1
相关论文
共 50 条
  • [31] Developing a Potency Assay for AAV-Based Genome Editing Vectors
    Cummings, Chris
    Hayes, Ryan
    Drouin, Lauren M.
    Hebben, Matthias
    MOLECULAR THERAPY, 2020, 28 (04) : 194 - 194
  • [32] Genome editing in nonhuman primates: approach to generating human disease models
    Chen, Y.
    Niu, Y.
    Ji, W.
    JOURNAL OF INTERNAL MEDICINE, 2016, 280 (03) : 246 - 251
  • [33] Somatic Genome Editing in Murine Lung via AAV Delivery of CRISPR
    Chen, Honglin
    Liang, Yuxin
    Foreman, Oded
    Caplazi, Patrick
    Warming, Soren
    Haley, Benjamin
    MOLECULAR THERAPY, 2020, 28 (04) : 133 - 133
  • [34] AAV-mediated in vivo genome editing in vascular endothelial cells
    Wu, Wenyi
    Yang, Yanhui
    Yao, Fei
    Dong, Lijun
    Xia, Xiaobo
    Zhang, Shaochong
    Lei, Hetian
    METHODS, 2021, 194 : 12 - 17
  • [35] Evolving Synthetic AAV Variants for Genome Editing in Immune Cell Populations
    Ark, Jonathan
    Nyberg, William
    Havlik, Patrick
    To, Angela
    Eyquem, Justin
    Asokan, Aravind
    MOLECULAR THERAPY, 2021, 29 (04) : 32 - 32
  • [36] CRISPR/Cas9-mediated genome editing via postnatal administration of AAV vector cures haemophilia B mice
    Tsukasa Ohmori
    Yasumitsu Nagao
    Hiroaki Mizukami
    Asuka Sakata
    Shin-ichi Muramatsu
    Keiya Ozawa
    Shin-ichi Tominaga
    Yutaka Hanazono
    Satoshi Nishimura
    Osamu Nureki
    Yoichi Sakata
    Scientific Reports, 7
  • [37] CRISPR/Cas9-mediated genome editing via postnatal administration of AAV vector cures haemophilia B mice
    Ohmori, Tsukasa
    Nagao, Yasumitsu
    Mizukami, Hiroaki
    Sakata, Asuka
    Muramatsu, Shin-ichi
    Ozawa, Keiya
    Tominaga, Shin-ichi
    Hanazono, Yutaka
    Nishimura, Satoshi
    Nureki, Osamu
    Sakata, Yoichi
    SCIENTIFIC REPORTS, 2017, 7
  • [38] Absolute Determination of Single-Stranded and Self -Complementary AAV Vector Genome Titers by Digital PCR
    Lock, Martin
    Alvira, Mauricio R.
    Grigorenko, Elena
    Patel, Sunali
    Jones, Tamara
    Slater, Marcia
    Wilson, James M.
    MOLECULAR THERAPY, 2012, 20 : S291 - S291
  • [39] CRISPR-Cas9-mediated genome editing delivered by a single AAV9 vector inhibits HSV-1 reactivation in a latent rabbit keratitis model
    Amrani, Nadia
    Luk, Kevin
    Singh, Pankaj
    Shipley, Mason
    Isik, Meltem
    Donadoni, Martina
    Bellizzi, Anna
    Khalili, Kamel
    Sariyer, Ilker K.
    Neumann, Donna
    Gordon, Jennifer
    Ruan, Guo-Xiang
    MOLECULAR THERAPY METHODS & CLINICAL DEVELOPMENT, 2024, 32 (03)
  • [40] Comparison between qPCR and ddPCR for AAV vector genome quantification
    Dorange, F.
    Alcindor, J.
    Boucheteil, J. B.
    Luc, C.
    Nguyen, L.
    Mavilio, F.
    Le Bec, C.
    HUMAN GENE THERAPY, 2017, 28 (12) : A110 - A111
12345